Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care E Mercuri, RS Finkel, F Muntoni, B Wirth, J Montes, M Main, ES Mazzone, ... Neuromuscular disorders 28 (2), 103-115, 2018 | 924 | 2018 |
Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics RS Finkel, E Mercuri, OH Meyer, AK Simonds, MK Schroth, RJ Graham, ... Neuromuscular Disorders 28 (3), 197-207, 2018 | 631 | 2018 |
International Charter of principles for sharing bio-specimens and data D Mascalzoni, ES Dove, Y Rubinstein, HJS Dawkins, A Kole, ... European Journal of Human Genetics 23 (6), 721-728, 2015 | 146 | 2015 |
Conducting research with the terminally ill: challenges and considerations K Beaver, K Luker, S Woods International Journal of Palliative Nursing 5 (1), 13-17, 1999 | 98 | 1999 |
God palliativ vård: etiska och filosofiska aspekter L Sandman, S Woods Newcastle University, 2003 | 88 | 2003 |
‘You should at least ask’. The expectations, hopes and fears of rare disease patients on large-scale data and biomaterial sharing for genomics research P McCormack, A Kole, S Gainotti, D Mascalzoni, C Molster, H Lochmüller, ... European Journal of Human Genetics 24 (10), 1403-1408, 2016 | 87 | 2016 |
218th ENMC International Workshop:: Revisiting the consensus on standards of care in SMA Naarden, The Netherlands, 19–21 February 2016 RS Finkel, T Sejersen, E Mercuri, E Bertini, K Chen, TO Crawford, ... neuromuscular Disorders 27 (6), 596-605, 2017 | 81 | 2017 |
Improving the informed consent process in international collaborative rare disease research: effective consent for effective research S Gainotti, C Turner, S Woods, A Kole, P McCormack, H Lochmüller, ... European Journal of Human Genetics 24 (9), 1248-1254, 2016 | 81 | 2016 |
The risk of re-identification versus the need to identify individuals in rare disease research MG Hansson, H Lochmüller, O Riess, F Schaefer, M Orth, Y Rubinstein, ... European Journal of Human Genetics 24 (11), 1553-1558, 2016 | 67 | 2016 |
The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: Report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on … F Muntoni, P McCormack, S Woods Neuromuscular Disorders 20 (5), 355-336, 2010 | 62 | 2010 |
EBOOK: Death's Dominion: Ethics at the End of Life S Woods McGraw-Hill Education (UK), 2006 | 62 | 2006 |
Nursing knowledge, theory and method revisited K Booth, M Kenrick, S Woods Journal of Advanced Nursing 26 (4), 804-811, 1997 | 55 | 1997 |
Primary care services received during terminal illness K Beaver, KA Luker, S Woods International journal of palliative nursing 6 (5), 220-227, 2000 | 54 | 2000 |
Users’ views of palliative care services: ethical implications S Woods, K Beaver, K Luker Nursing ethics 7 (4), 314-326, 2000 | 44 | 2000 |
Therapeutic misconception: hope, trust and misconception in paediatric research S Woods, LE Hagger, P McCormack Health care analysis 22, 3-21, 2014 | 41 | 2014 |
Respect for persons, autonomy and palliative care S Woods Medicine, Health Care and Philosophy 8, 243-253, 2005 | 41 | 2005 |
Disputing the ethics of research: the challenge from bioethics and patient activism to the interpretation of the Declaration of Helsinki in clinical trials S Woods, P Mccormack Bioethics 27 (5), 243-250, 2013 | 37 | 2013 |
Introduktion L Sandman, S Woods God palliativ vård: etiska och filosofiska aspekter, 2003 | 35 | 2003 |
The risks of therapeutic misconception and individual patient (n= 1)“trials” in rare diseases such as Duchenne dystrophy A Aartsma-Rus, P Furlong, E Vroom, GJ van Ommen, E Niks, C Straathof, ... Neuromuscular disorders 21 (1), 13-15, 2011 | 29 | 2011 |
Rare diseases and now rare data? D Mascalzoni, BM Knoppers, S Aymé, M Macilotti, H Dawkins, S Woods, ... Nature reviews genetics 14 (6), 372-372, 2013 | 25 | 2013 |